Martina Biggioggero

Twelve‐Year Retention Rate of First‐Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real‐Life Data From a Local Registry

Ennio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero et al. · Arthritis Care & Research · 2015 · 97 citations

Medicine, Pharmacology, Pharmacotherapy +13

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies

Ennio Giulio Favalli, Martina Biggioggero, Antonio Marchesoni et al. · Lara D. Veeken · 2014 · 89 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

Ennio Giulio Favalli, Serena Bugatti, Catherine Klersy et al. · Arthritis Research & Therapy · 2020 · 54 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors

Rolando Cimaz, Marie-Angélique Cazalis, C. Reynaud et al. · Annals of the Rheumatic Diseases · 2007 · 51 citations · Full text

Life Sciences, Genetics, Immunology +17

Eight‐Year Retention Rate of First‐Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis

Ennio Giulio Favalli, Carlo Selmi, Andrea Becciolini et al. · Arthritis Care & Research · 2016 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16